TP53 and Li-Fraumeni syndrome: In 70–80% of cases with clinical manifestations of LFS, germline mutations in the TP53 gene are detected [3], while estimates suggest that the contribution of de novo mutation variants ranges from 7 to 20% out of identified cases [4].